Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
7.26
+0.05 (0.69%)
At close: Jul 24, 2026, 4:00 PM EDT
7.05
-0.21 (-2.89%)
After-hours: Jul 24, 2026, 7:58 PM EDT
Aspire Biopharma Holdings Market Cap
Aspire Biopharma Holdings has a market cap or net worth of $9.4 million as of July 24, 2026. Its market cap has decreased by -53.69% in one year.
Market Cap
9.40M
Enterprise Value
5.05M
1-Year Change
-53.69%
Ranking
Category
Stock Price
$7.26
ChartMarket Cap Chart
Since April 11, 2022, Aspire Biopharma Holdings's market cap has decreased from $349.64M to $9.40M, a decrease of -97.31%. That is a compound annual growth rate of -56.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 9.40M | -33.67% |
| Dec 31, 2025 | 14.18M | -84.12% |
| Dec 18, 2024 | 89.29M | -8.80% |
| Dec 29, 2023 | 97.91M | -73.55% |
| Dec 30, 2022 | 370.15M | 5.86% |
| Apr 11, 2022 | 349.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Psyence Biomedical | 11.25M |
| Exicure | 11.22M |
| Lunai Bioworks | 10.56M |
| BioVie | 10.33M |
| Theriva Biologics | 10.23M |
| Chemomab Therapeutics | 9.79M |
| BioCardia | 9.67M |
| Curis | 9.53M |